Skip navigation
Skip navigation

Invited commentary: Hormone therapy risks and benefits - The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis

Banks, Emily; Canfell, Karen


Worldwide evidence on menopausal hormone therapy shows that it does not reduce coronary heart disease (CHD) risk and that it increases the risks of breast cancer, stroke, and venous thromboembolism. These risks are not offset by reductions in hip fracture risk. Consequently, the Food and Drug Administration and other drug regulatory authorities agree that hormone therapy should be used chiefly for short-term relief of menopausal symptoms. Continuing speculation relates to the "postmenopausal...[Show more]

CollectionsANU Research Publications
Date published: 2009
Type: Journal article
Source: American Journal of Epidemiology
DOI: 10.1093/aje/kwp113


File Description SizeFormat Image
01_Banks_Invited_commentary:_Hormone_2009.pdf91.11 kBAdobe PDF    Request a copy

Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.

Updated:  20 July 2017/ Responsible Officer:  University Librarian/ Page Contact:  Library Systems & Web Coordinator